BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17154227)

  • 1. Fetal anomaly scan potentially will replace routine AFAFP assays for the detection of neural tube defects.
    Kooper AJ; de Bruijn D; van Ravenwaaij-Arts CM; Faas BH; Creemers JW; Thomas CM; Smits AP
    Prenat Diagn; 2007 Jan; 27(1):29-33. PubMed ID: 17154227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
    Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sonography, a complementary examination to alpha-fetoprotein testing for fetal neural tube defects.
    Hashimoto BE; Mahony BS; Filly RA; Golbus MS; Anderson RL; Callen PW
    J Ultrasound Med; 1985 Jun; 4(6):307-10. PubMed ID: 2409295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
    Chen CP
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):283-90. PubMed ID: 18935990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage II ultrasound examination for the diagnosis of fetal abnormalities with an elevated amniotic fluid alpha-fetoprotein concentration.
    Hobbins JC; Venus I; Tortora M; Mayden K; Mahoney MJ
    Am J Obstet Gynecol; 1982 Apr; 142(8):1026-9. PubMed ID: 6176125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine amniotic fluid alphafetoprotein assay: experience with 40,000 pregnancies.
    Crandall BF; Matsumoto M
    Am J Med Genet; 1986 May; 24(1):143-9. PubMed ID: 2422932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of amniotic fluid alpha-fetoprotein: sonographic evaluation.
    Robbin M; Filly RA; Fell S; Goldstein RB; Callen PW; Goldberg JD; Golbus MS
    Radiology; 1993 Jul; 188(1):165-9. PubMed ID: 7685529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine measurement of amniotic fluid alpha-fetoprotein and acetylcholinesterase: the need for a reevaluation.
    Flick A; Krakow D; Martirosian A; Silverman N; Platt LD
    Am J Obstet Gynecol; 2014 Aug; 211(2):139.e1-6. PubMed ID: 24530818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum alpha-fetoprotein screening: promise not yet fulfilled.
    Nadler HL; Simpson JL
    Am J Obstet Gynecol; 1979 Sep; 135(1):1-2. PubMed ID: 89812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of AFP in amniotic fluid: comparison of three automated techniques].
    Leguy MC; Tavares Sdos R; Tsatsaris V; Lewin F; Clauser E; Guibourdenche J
    Ann Biol Clin (Paris); 2011; 69(4):441-6. PubMed ID: 21896409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of 12 years' combined maternal serum alpha-fetoprotein screening and ultrasound fetal monitoring for prenatal detection of fetal malformations in Havana City, Cuba.
    Rodríguez L; Sánchez R; Hernández J; Carrillo L; Oliva J; Heredero L
    Prenat Diagn; 1997 Apr; 17(4):301-4. PubMed ID: 9160380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic use of meternal serum alpha-fetoprotein levels.
    Cowchock FS; Jackson LG
    Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks for fetal abnormalities after very and moderately elevated AF-AFPs.
    Crandall BF; Chua C
    Prenat Diagn; 1997 Sep; 17(9):837-41. PubMed ID: 9316128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal detection of neural tube defects. VI. Experience with 20,000 pregnancies.
    Milunsky A
    JAMA; 1980 Dec; 244(24):2731-5. PubMed ID: 6160265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The usefulness of the level of alpha-fetoprotein (AFP) and electrophoresis of amniotic acetylcholinesterase for the detection of selected congenital malformations].
    Lemonnier MC; Julian C; Aymé S; Philip N; Voeckel MA; Gamerre M; Mattéi JF
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(3):280-4. PubMed ID: 1693158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal plasma alpha-fetoprotein screening for fetal neural tube defects.
    Brock DJ; Scrimgeour JB; Steven J; Barron L; Watt M
    Br J Obstet Gynaecol; 1978 Aug; 85(8):575-81. PubMed ID: 80224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.